期刊文献+

大肠杆菌不耐热肠毒素(LT)无毒突变体mLT63在大肠杆菌中的融合表达及纯化 被引量:2

Expression and purification of the fusion protein of the avirulent mutant mLT63 from heat-labile enterotoxin of E.coli
在线阅读 下载PDF
导出
摘要 目的在大肠杆菌中表达并纯化大肠杆菌不耐热肠毒素无毒突变体mLT63融合蛋白,并探索其免疫反应性。方法采用不同的诱导温度,IPTG浓度,葡萄糖含量,pH值以及不同的培养基优化重组菌TB1(pMAL-c2X-mlt)的表达条件,表达产物经超声粉碎,超声上清经初步盐析、应用直链淀粉亲和层析柱纯化,Western blot鉴定纯化产物的免疫学反应性。结果融合蛋白在诱导表达产物中的含量达到16.11%,纯化产物的纯度达到72.58%。纯化产物能够被抗CT血清所识别。结论成功表达并纯化出了大肠杆菌不耐热肠毒素无毒突变体mLT63,获得了纯度较高并具有良好免疫反应性的融合蛋白。 To express and purify the fusion protein of the avirulent mutant mLT63 from heat-labile enterotoxin of E. coli and to determine its immunoreactivity with specific antibodies, different conditions for expression, such as induction temperature, concentration of IPTG, content of glucose, pH value and different culture media were investigated in order to optimize the expression of the recombinant strain TB1 (pMAL-c2X-mlt). The expressed product was purified through amylose pre-packed column after treatment with ultrasonic disintegrator and salting out of the supernatant after ultrasonication. SDS-PAGE was used for the detection of the expressed product and Western blot was employed to determine the immunoreactivity of mLT63 with rabbit anti-cholera toxin (CT) serum. It was demonstrated that the content of the fusion protein from recombinant mLT63 was found to be 16.11% with a purity of 72.58% after purification. In addition, this fusion protein could be recognized by rabbit anti-CT serum, with high immunoreactivity. In the present investigation, the fusion protein of the avirulent mutant mLT63 from heat-labile enterotoxin of E. coli was succesfully obtained.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2006年第9期821-824,共4页 Chinese Journal of Zoonoses
关键词 大肠杆菌 不耐热肠毒素 突变体 融合蛋白 表达 纯化 Escherlchia coli heat-labile enterotoxin mutants fusion protein expression purification
  • 相关文献

参考文献8

  • 1Middlebrook JL,Dorland RB.Bacterial toxins:cellular mechanisms of action[J].Mierobiol Rev,1984,48(3):199-221.
  • 2Sixma TK,Pronk SE,Kalk KH.Crystal structure of a cholera toxin-related heat-labile enterotoxin from E.coli[J].Nature,1991,351(6325):371-377.
  • 3Clements JD,Yancy RJ,Finkelstein RA.Properties of homogeneous heat-labile enterotoxin from E.coli[J].Infect Immun,1980,29(1):91-97.
  • 4Van den Akker F,Pizza M,Rappuoli R,et al.Crystal structure of a nontoxic mutant of heat-labile enterotoxin,which is a potent mucosal adjuvant[J].Protein.Sci,1997,6(12):2650-2654.
  • 5申晓靖,段广才,郗园林,代丽萍,康巧珍.大肠杆菌不耐热肠毒素基因克隆和无毒突变体mLT63的构建及序列分析[J].河南医学研究,2005,14(2):100-103. 被引量:4
  • 6Ausuel FM,Kingston RE,seidman JG,et al.精编分子生物学实验指南[M].4版.北京:科学出版社,2005:379-383.
  • 7J萨姆布鲁克 DW拉塞尔 金冬雁 黎孟枫 译.分子克隆实验指南第3版[M].北京:科学出版社,2002.27-30.
  • 8冯强,蔡绍皙,杨珺,罗萍,张卫军,邹全明.大肠杆菌不耐热肠毒素的表达及其纯化保存策略[J].生物工程学报,2003,19(5):532-537. 被引量:9

二级参考文献10

  • 1Middlebrook JL, Dorland RB. Bacterial toxins: cellular mechanisms of action[J]. Microbiol Rev, 1984,48(3): 199-221.
  • 2Domenighini M, Magagnoli C, Pizza M, et al. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins [ J]. Mol Microbiol,1994,14(1) :41-50.
  • 3Pizza M,Domenighini M,Hol W,et al. Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis[ J]. Mol Microbiol, 1994,14( 1 ) :51-60.
  • 4Pizza M, Giuliani MM, Fontana MR, et al. Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants [ J ]. Vaccine, 2001,19 ( 17~ 19) :2534-2541.
  • 5SambrookJ FritschEF ManiatisT.金冬雁 黎孟枫译.分子克隆试验指南[M].第二版[M].北京:科学出版社,1996.25-26.
  • 6S.R.Maloy.徐建国等译.医用细菌遗传学试验指南[M].北京:科学出版社,1998.72-76.
  • 7SambrookJ FritschEF ManiatisT.黄培堂等译.分子克隆试验指南.第三版[M].北京:科学出版社,2002.1109-1112.
  • 8Willshaw GA,Barclay EA,Smith HR,et al. Molecular comparison of plasmids encoding heat-labile enterotoxin isolated from Escherichia coli strains of human origin[J]. J Bacteriol, 1980,143( 1 ): 168-175.
  • 9王缚鲲,张卫军,邹全明,郭学青,于长青,曾浩.幽门螺杆菌热休克蛋白A亚单位基因工程菌的发酵[J].中国生物制品学杂志,2001,14(2):84-86. 被引量:4
  • 10冯强,邹全明,蔡绍皙,毛旭虎,冉向阳.LT质粒的新法提取及无毒突变体LTS63K的构建和序列分析[J].免疫学杂志,2002,18(5):385-388. 被引量:4

共引文献14

同被引文献13

  • 1申晓靖,段广才,郗园林,代丽萍,康巧珍.大肠杆菌不耐热肠毒素基因克隆和无毒突变体mLT63的构建及序列分析[J].河南医学研究,2005,14(2):100-103. 被引量:4
  • 2张荣光,段广才,范清堂,郗园林,代丽萍.幽门螺杆菌感染的昆明小鼠模型的建立[J].中华医学杂志,2006,86(12):857-859. 被引量:15
  • 3李晶,张建中.幽门螺杆菌黏附素及受体研究与疫苗发展[J].中国人兽共患病学报,2006,22(6):580-582. 被引量:5
  • 4黄学勇,段广才,范清堂,郗园林,黄志刚,宋春花.幽门螺杆菌基因hpaA克隆、融合表达和鉴定[J].中国人兽共患病学报,2007,23(3):274-277. 被引量:1
  • 5Verweij WR, Haan L, Holtrop M, et al. Mucosal irnmunoadjurant activity of recombinant Escherichia coli heat labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen[J]. Vaccine, 1998, 16(20): 2069 -2076.
  • 6Parez N, Fourgeux C, Mohamed A, et al. Rectal immunization with rotavirus virus like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection[J]. Virol, 2006, 80(4):1752-1761.
  • 7Park KS, Ono T, Rokuda M, et al. Cytotoxicity and enterotoxicity of the thermostable direct hemolysin-deletion mutants of Vibrio parahaemolyticus [J]. Microbiol Immunol, 2004, 48(4): 313-318.
  • 8Keenan JI, Allardyce RA, Bagshaw PF. Lack of protection following immunisation with H. pylori membrane vesicles highlights antigenic differences between H. fells and H. pylori [J]. FEMS Microbiol Lett, 1998, 161(1) : 21 -27.
  • 9Ohata H,Kitauchi S,Yoshimura N,et al.Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer[J].Int J Cancer,2004,109(1):138-143.
  • 10Carlsonhn E,Nystrom J,Bolin I,et al.HpaA is essential for Helicobacter pylori colonization in mice[J].Infect Immun,2006,74(2):920-926.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部